NRX Pharmaceuticals, Inc.
About NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.2M
- Net income
- -$28.6M
- Total assets
- $13.0M
- Market cap
- $177.2M
- Gross margin
- 58.8%
- Operating margin
- -1324.4%
- Net margin
- -2336.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.2M
- Cost of revenue
- $505.0K
- Gross profit
- $720.0K
- Operating expenses
- $16.9M
- Operating income
- -$16.2M
- Income tax
- $0
- Net income
- -$28.6M
- EPS (basic)
- $-1.34
Balance sheet
- Total assets
- $13.0M
- Current assets
- $8.9M
- Total liabilities
- $28.9M
- Current liabilities
- $28.6M
- Shareholders’ equity
- -$15.9M
Cash flow
- Operating cash flow
- -$14.1M
- Investing cash flow
- -$2.8M
- Financing cash flow
- $23.3M
- Net cash flow
- $6.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $177.2M
- Shares outstanding
- 40.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 25, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $28.6M in FY2025.
- Gross margin of 58.8%, net margin -2336.5%.
- Trading 6% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NRX Pharmaceuticals, Inc..
Write a review
News about NRX Pharmaceuticals, Inc.
News & sentiment via Polygon.io
